Drug intelligence / Profile preview

PIROMAL

Development stage
Unknown
Lead developer
Aurora Biofarma
Administration
Oral
01

Overview

PIROMAL is a CE-certified medical device (CE 0426) developed by Aurora Biofarma for the prevention and treatment of gastric hyperacidity, gastroesophageal reflux (GERD), and laryngopharyngeal reflux (LPR). It is also indicated for the protection of the gastric and esophageal mucosa. The product contains a combination of active ingredients, including potassium alginate (or sodium alginate), calcium carbonate, potassium bicarbonate, and *Tamarindus indica* seed extract. PIROMAL functions through a physical mechanism rather than a pharmacological one; upon contact with gastric acid, the alginate forms a viscous "raft" or gel barrier that floats on the stomach contents, physically preventing the reflux of acid into the esophagus. Simultaneously, the carbonate and bicarbonate components help neutralize excess gastric acid. It is available in chewable tablets and gel stick packs.

Brand names
PIROMAL

Beyond the preview

Go deeper on PIROMAL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIROMAL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call